ExploreWatchlistsPricing
  1. JP-listed companies
  2. Mochida Pharmaceutical Co.,Ltd.
  3. Financials
  4. Earnings per share

Mochida Pharmaceutical Co.,Ltd. (4534)

Market cap
¥122.5B
P/E ratio
14.2x
A Japanese pharmaceutical company that develops and sells prescription drugs and healthcare products through a network of manufacturing and sales subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 2025160.4+26.47%
Mar 31, 2024126.8-29.13%
Mar 31, 2023178.9-35.50%
Mar 31, 2022277.4+24.79%
Mar 31, 2021222.3+89.09%
Mar 31, 2020117.6-44.77%
Mar 31, 2019212.9-53.17%
Mar 31, 2018454.6+5.84%
Mar 31, 2017429.5+4.63%
Mar 31, 2016410.5+8.80%
Mar 31, 2015377.3-22.79%
Mar 31, 2014488.7+10.49%
Mar 31, 2013442.3+2.74%
Mar 31, 2012430.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat